Research analysts at Cantor Fitzgerald decreased their FY2025 earnings per share estimates for Beam Therapeutics in a note issued to investors on Wednesday, February 26th. Cantor Fitzgerald analyst R.

As an enterprise engaged in the development, manufacturing and commercialization of specialty plasma-derived therapeutics, ...

Equities research analysts at Cantor Fitzgerald issued their FY2024 earnings per share (EPS) estimates for SoundHound AI in a research report issued to clients and investors on Monday, February 24th.

Blackwell is still in its early days, but at $11 billion, it made up nearly a third of Nvidia's data-center revenue, Cantor Fitzgerald analyst C.J. Muse noted. (Nvidia's data-center business ...

Fintel reports that on February 26, 2025, Cantor Fitzgerald downgraded their outlook for Jazz Pharmaceuticals (NasdaqGS:JAZZ) ...

Cantor Fitzgerald analyst Andres Sheppard reiterated a Buy rating on Intuitive Machines (LUNR – Research Report) yesterday and set a price ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

Lucid could see continued delivery momentum with the Gravity SUV launch, but analysts see near-term worries with a CEO search ...